Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog

J Vet Med Sci. 2007 Feb;69(2):201-4. doi: 10.1292/jvms.69.201.

Abstract

A 10-year-old Maltese dog was presented with abdominal distention and dyspnea. Cytological examination of pleural and peritoneal effusion was suggestive of malignant effusion of glandular origin. Numerous, multifocal, tan to white nodules were disseminated throughout the surface of the abdominal organs and peritoneum at biopsy. Histologically, the tumors were revealed to be an epithelial type of mesothelioma. Neoplastic cells co-expressed cytokeratin and vimentin. Intravenous administration of cisplatin was chosen as the treatment. During treatment, the dog's overall body condition improved and the clinical signs were relieved without significant side effects. The survival time from diagnosis to sudden death by unknown cause was 153 days.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cisplatin / therapeutic use*
  • Dog Diseases / drug therapy*
  • Dog Diseases / pathology
  • Dogs
  • Fatal Outcome
  • Female
  • Histocytochemistry / veterinary
  • Mesothelioma / drug therapy
  • Mesothelioma / pathology
  • Mesothelioma / veterinary*
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / pathology
  • Peritoneal Neoplasms / veterinary*
  • Pleural Neoplasms / drug therapy
  • Pleural Neoplasms / pathology
  • Pleural Neoplasms / veterinary*

Substances

  • Antineoplastic Agents
  • Cisplatin